Reorganizing the Global Pharmacovigilance Function

Summer Foote

An F200 pharma company was reevaluating the operating model of its global drug safety and pharmacovigilance functions. Looking for help assessing cost, quality, and productivity impact of different resourcing scenarios, the group’s head turned to BTG. We delivered an independent pharmacovigilance organization specialist and former engagement lead in Accenture’s life science practice. She worked with internal executives to evaluate the most efficient model, then develop detailed organization-wide communication and implementation plans.

Previous Article
Meatless Market Landscape
Meatless Market Landscape

The Chief Growth Officer at an F500 food and beverage company was exploring opportunities in plant-based pr...

Next Article
Interim Head of Innovation
Interim Head of Innovation

A $5 billion technology company was looking to diversify revenue and develop its next billion-dollar busine...


Talk with BTG to learn more about our on-demand talent.

First Name
Last Name
I would like to receive the latest expert insights and news from Business Talent Group.
By registering, you agree to the processing of your personal data by Business Talent Group as described in the Privacy Statement.
View our Privacy Policy and Cookie Policy
Thank you! We will be in touch shortly.
Error - something went wrong!